Gene Logic: Your Partner in Drug Development
Gene Logic provides innovative drug discovery and development solutions to the pharmaceutical industry. Our solutions span the pharmaceutical development pipeline, helping customers develop therapeutically and commercially valuable compounds in a more timely, efficient, and cost-effective manner. Our customers can use our solutions to understand the effect of a compound on biological processes, and to identify, evaluate and measure critical safety, efficacy, and other patient-related factors so that they may better assess the likely therapeutic and commercial value of their targets and compounds.
Our portfolio of solutions consists of:
Genomics and Toxicogenomics: We help customers to discover and prioritize drug targets, identify biomarkers, predict toxicity and provide insights into efficacy of specific compounds through the use of gene expression technologies, proprietary reference databases and bioinformatics software and professional services. Specific products and services include:
BioExpress® System
ASCENTA® System
ToxExpress® System
ToxScreen™ Reports
Mechanism of Toxicity (MOT) Reports
Genesis Enterprise System® Software
Microarray Data Generation and Analysis™ Services
Preclinical Services: We enable customers to assess the safety and pharmacologic effects of candidate compounds with the intention of gaining regulatory approval to proceed with human trials on prioritized compounds, through testing research studies and related laboratory services. Specific study services include:
General Toxicology
Reproductive and Developmental Toxicology
Safety Pharmacology
Bioanalytical Services
Pathology Services
Clinical Pathology Services
Drug Repositioning and Selection™ Program: We work with pharmaceutical companies to find new development paths for failed, stalled, or deprioritized clinical-stage drug candidates, to prioritize promising lead candidates, or to identify additional applications for marketed drugs. Our unique, integrated multiple technologies allow us to assess hundreds of human disease therapeutic indications for each drug candidate. Specific partnership arrangements include:
Drug Repositioning
Compound Selection
Market Expansion
By thinking as a partner – listening to our clients and understanding their needs – Gene Logic provides customers with the insights to find the full therapeutic and commercial potential within each drug candidate in their developmental pipeline.
Last Updated: 04-06-2006